Form 4: Guardant Health Director Sells Shares Under 10b5-1 Plan

Guardant Health Director Musa Tariq sold 348 shares of common stock at $88.09 per share under a pre-arranged trading plan.

Summary

• Musa Tariq, a Director of Guardant Health, Inc. (GH), reported a sale of common stock.
• The transaction involved the disposition of 348 shares.
• The shares were sold at a price of $88.09 per share.
• The sale was executed on March 18, 2026.
• Following this transaction, Musa Tariq beneficially owns 8,394 shares of Guardant Health common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which typically minimizes speculative interpretation regarding the company's immediate prospects.

Negatives

• A director sold 348 shares of company common stock.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, especially those executed under a 10b5-1 plan, are common and do not always signal a negative outlook for the company. Such plans allow insiders to sell shares at predetermined times to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders: May interpret the director's sale differently, though a 10b5-1 plan mitigates negative signaling.

Key Dates

Recommendation

The filing reports a routine insider sale under a 10b5-1 plan, which is a pre-scheduled transaction and does not inherently signal a change in the company's fundamentals or future prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Guardant Health, GH, Musa Tariq, Insider Trading, Form 4, Stock Sale, Director Transaction, 10b5-1 Plan